U.S. OKs use of Genentech's Avastin in lung cancer
U.S. regulators agreed to expand the use of Genentech Inc.'s drug Avastin, now used against colon cancer, to include treatment of the most common type of lung cancer, the company said on Wednesday. Avastin, the first…
2 min read